Mapping the perturbome network of cellular perturbations

被引:27
作者
Caldera, Michael [1 ]
Mueller, Felix [1 ]
Kaltenbrunner, Isabel [1 ]
Licciardello, Marco P. [1 ,2 ]
Lardeau, Charles-Hugues [1 ,3 ]
Kubicek, Stefan [1 ]
Menche, Joerg [1 ]
机构
[1] Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14, A-1090 Vienna, Austria
[2] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London, England
[3] AstraZeneca, Hit Discovery, Discovery Sci, R&D, Alderley Pk, Macclesfield, Cheshire, England
关键词
DRUG; DATABASE; SIMILARITY; RESOURCE; CANCER;
D O I
10.1038/s41467-019-13058-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Drug combinations provide effective treatments for diverse diseases, but also represent a major cause of adverse reactions. Currently there is no systematic understanding of how the complex cellular perturbations induced by different drugs influence each other. Here, we introduce a mathematical framework for classifying any interaction between perturbations with high-dimensional effects into 12 interaction types. We apply our framework to a large-scale imaging screen of cell morphology changes induced by diverse drugs and their combination, resulting in a perturbome network of 242 drugs and 1832 interactions. Our analysis of the chemical and biological features of the drugs reveals distinct molecular fingerprints for each interaction type. We find a direct link between drug similarities on the cell morphology level and the distance of their respective protein targets within the cellular interactome of molecular interactions. The interactome distance is also predictive for different types of drug interactions.
引用
收藏
页数:14
相关论文
共 66 条
  • [1] Combinatorial drug therapy for cancer in the post-genomic era
    Al-Lazikani, Bissan
    Banerji, Udai
    Workman, Paul
    [J]. NATURE BIOTECHNOLOGY, 2012, 30 (07) : 679 - 691
  • [2] HIPPIE v2.0: enhancing meaningfulness and reliability of protein-protein interaction networks
    Alanis-Lobato, Gregorio
    Andrade-Navarro, Miguel A.
    Schaefer, Martin H.
    [J]. NUCLEIC ACIDS RESEARCH, 2017, 45 (D1) : D408 - D414
  • [3] Activities at the Universal Protein Resource (UniProt) (vol 42, pg D198, 2014)
    Apweiler, Rolf
    [J]. NUCLEIC ACIDS RESEARCH, 2014, 42 (11) : 7486 - 7486
  • [4] Drug repositioning: Identifying and developing new uses for existing drugs
    Ashburn, TT
    Thor, KB
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) : 673 - 683
  • [5] Human gene essentiality
    Bartha, Istvan
    di Iulio, Julia
    Venter, J. Craig
    Telenti, Amalio
    [J]. NATURE REVIEWS GENETICS, 2018, 19 (01) : 51 - 62
  • [6] Drug-induced hyperuricaemia and gout
    Ben Salem, C.
    Slim, Raoudha
    Fathallah, Neila
    Hmouda, Houssem
    [J]. RHEUMATOLOGY, 2017, 56 (05) : 679 - 688
  • [7] Gene essentiality and synthetic lethality in haploid human cells
    Blomen, Vincent A.
    Majek, Peter
    Jae, Lucas T.
    Bigenzahn, Johannes W.
    Nieuwenhuis, Joppe
    Staring, Jacqueline
    Sacco, Roberto
    van Diemen, Ferdy R.
    Olk, Nadine
    Stukalov, Alexey
    Marceau, Caleb
    Janssen, Hans
    Carette, Jan E.
    Bennett, Keiryn L.
    Colinge, Jacques
    Superti-Furga, Giulio
    Brummelkamp, Thijn R.
    [J]. SCIENCE, 2015, 350 (6264) : 1092 - 1096
  • [8] The Unified Medical Language System (UMLS): integrating biomedical terminology
    Bodenreider, O
    [J]. NUCLEIC ACIDS RESEARCH, 2004, 32 : D267 - D270
  • [9] Microscopy-Based High-Content Screening
    Boutros, Michael
    Heigwer, Florian
    Laufer, Christina
    [J]. CELL, 2015, 163 (06) : 1314 - 1325
  • [10] Computing continuous core/periphery structures for social relations data with MINRES/SVD
    Boyd, John P.
    Fitzgerald, William J.
    Mahutga, Matthew C.
    Smith, David A.
    [J]. SOCIAL NETWORKS, 2010, 32 (02) : 125 - 137